Cargando…
Profile of crizanlizumab and its potential in the prevention of pain crises in sickle cell disease: evidence to date
Sickle cell disease (SCD) is one of the most common inherited blood disorders globally. It is a grouping of autosomal recessive genetic disorders identified by a genetic mutation that replaces glutamic acid with valine at the sixth amino acid on the hemoglobin β-globin chain. Millions of people arou...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720158/ https://www.ncbi.nlm.nih.gov/pubmed/31507334 http://dx.doi.org/10.2147/JBM.S191423 |